# Nuclide record cu-64-dotatate (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/cu-64-dotatate/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "cu-64-dotatate" ;
  schema:name "Copper-64 dotatate"@en ;
  schema:alternateName "64Cu-DOTATATE"@en, "Detectnet"@en, "Detectnet" ;
  schema:description "An injectable tracer that sticks to a marker (somatostatin receptor) many neuroendocrine tumours carry. A PET scan afterwards shows where those tumours are, including small deposits that other scans can miss."@en ;
  schema:url <https://nuclide.cc/drugs/cu-64-dotatate/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/Drugsatfda_Docs/Label/2020/213227s000lbl.Pdf>, <https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213227Orig1s000Approv.pdf>, <https://pubmed.ncbi.nlm.nih.gov/31924723/> ;
  nuclide:status "approved" ;
  nuclide:tag "SSTR2", "NET imaging", "copper-64" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 2020: PET localisation of somatostatin receptor-positive neuroendocrine tumours in adult patients" ;
  nuclide:related <https://nuclide.cc/drugs/ga68-dotatate/>, <https://nuclide.cc/drugs/ga-68-dotatoc/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/cu-64/> ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/>, <https://nuclide.cc/indications/pancreatic-net/>, <https://nuclide.cc/indications/small-intestinal-net/> ;
  nuclide:technologies <https://nuclide.cc/technologies/sstr-pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:targets <https://nuclide.cc/targets/sstr2/> ;
  nuclide:companies <https://nuclide.cc/companies/radiomedix/>, <https://nuclide.cc/companies/curium/> .